Encompass Health Corporation Restricted Cash and Cash Equivalents
Encompass Health Corporation (EHC) had Restricted Cash and Cash Equivalents of $30.70 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-02-26
- 2025-12-31: Restricted Cash and Cash Equivalents $30.70M.
- 2024-12-31: Restricted Cash and Cash Equivalents $37.70M.
- 2023-12-31: Restricted Cash and Cash Equivalents $35.10M.
- 2022-12-31: Restricted Cash and Cash Equivalents $31.60M.
| Period end | Restricted Cash and Cash Equivalents | Restricted Cash and Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $30.70M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $37.70M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $35.10M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $31.60M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $62.90M 10-K · filed 2023-02-27 | $65.50M 10-K · filed 2022-02-25 |
| 2020-12-31 | $86.90M 10-K · filed 2022-02-25 | |
| 2019-12-31 | $64.80M 10-K · filed 2021-02-26 | |
| 2018-12-31 | $64.30M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $62.40M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |